نتائج البحث - "Dolor crónico no oncológico"

المصدر: Revista de la Sociedad Española del Dolor v.28 n.2 2021
SciELO España. Revistas Científicas Españolas de Ciencias de la Salud
instname
SciELO España: Revistas Científicas Españolas de Ciencias de la Salud
Instituto de Salud Carlos III (ISCIII)

مصطلحات موضوعية: trastornos relacionados con opioides, Opioide, Anesthesiology and Pain Medicine, dolor crónico no oncológico, uso indebido de opioides, dolor crónico

وصف الملف: text/html

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b6d1ccf7b50b5666e0532360c3a0ed42
https://doi.org/10.20986/resed.2021.3845/2020

6

[Quasi-experimental study of an intervention on the pharmacological management of non-oncological chronic pain in Primary Care]

المؤلفون: Juan Antonio, García Vicente, Cristina, Vedia Urgell, Roser, Vallès Fernández, Dolores, Reina Rodríguez, Sara, Rodoreda Noguerola, Daniel, Samper Bernal

المصدر: Atencion Primaria

مصطلحات موضوعية: Opioide, Primary Health Care, Dolor crónico no oncológico, Ansiolítico-hipnótico, Intervention, Opioid, Anxiolytic-hypnotic, Fentanyl citrate, Intervención, Analgesics, Opioid, Fentanyl, Imágenes, Fentanilo citrato, Lidocaína transdérmica, Humans, Lidocaine patch, Prospective Studies, Chronic Pain, Non-oncological chronic pain

URL الوصول: https://explore.openaire.eu/search/publication?articleId=pmid________::867c863fd812621eddd5b9465f0bc138
https://pubmed.ncbi.nlm.nih.gov/31727390

View record from ScienceDirect

7

Factores asociados a uso inapropiado de opioides en dolor crónico no oncológico en una población de Bogotá

المؤلفون: Rondón Lizarazo, Maria Paula, Salazar Rodríguez, Diana Maritza

المساهمون: Daza Vergara, José Alejandro, Isaza Narváez, Ana Milena, Aguilera, Paula, Pedraza Flechas, Ana Maria

المصدر: 1. Campbella, G., et al. The Pain and Opioids IN Treatment study: characteristics of a cohort using opioids to manage chronic non-cancer pain. Pain 2015; Feb;156(2):231-42.
2. Sehgal, N., Manchikanti, L., Smith, HS. Prescription Opioid Abuse in Chronic Pain: A Review of Opioid Abuse Predictors and Strategies to Curb Opioid Abuse. Pain Physician. 2012 Jul;15(3 Suppl):ES67-92.
3. Kaye, A.D. et al. Prescription Opioid Abuse in Chronic Pain: An Updated Review of Opioid Abuse Predictors and Strategies to Curb Opioid Abuse: Part 1. Pain Physician 2017; 20: S93-S109.
4. Airam, A., Hammam A., Gururau S. Prevention of Opioid Abuse in Chronic Non-Cancer Pain: An Algorithmic, Evidence Based Approach. Pain Physician 2012; 15:ES177-ES189.
5. Vogt MT, Kwoh CK, Cope DK, Osial TA, Culyba M, Starz TW. Analgesic usage for low back pain: impact on health care costs and service use. Spine. 2005;30:1075–1081.
6. Voon P, Karamouzian M, Kerr T.Chronic pain and opioid misuse: a review of reviews. Substance Abuse Treatment, Prevention, and Policy 2017; 12:36.
7. Palmer R.E, et al. The prevalence of problem opioid use in patients receiving chronic opioid therapy: computer-assisted review of electronic health record clinical notes. Pain 2015; Jul;156(7):1208-14.
8. Boyd, C., et al. Motives for Medical Misuse of Prescription Opioids Among Adolescent. J Pain. 2013 Oct; 14(10): 1208–1216.
9. Carter, J., et al. Factors predicting development of opioid use disorders among individuals who receive an initial opioid prescription: Mathematical modeling using a database of commercially-insured individuals. Drug Alcohol Depend. 2014 May 1;138:202-8.
11. Müller-Schwefe, G. Dynamic risk factors in the misuse of opioid analgesics. J Psychosom Res. 2012 Jun;72(6):443-51.
12. Volkow, N., McLellan, A.T. Opioid Abuse in Chronic Pain — Misconceptions and Mitigation Strategies. Engl J Med 2016; 374:1253-1263.
13. Guerrero A, Gómez P. VIII Estudio Nacional de Dolor 2014-Prevalencia del dolor crónico en Colombia. Asociación Colombiana para el Estudio de Dolor. 2016.
14. Just J. et al. Risk of opioid misuse in chronic non-cancer pain in primary care patients-a cross sectional study. BMC Family Practice 2018; 19:92.
15. Gobierno Nacional de la República de Colombia. Estudio Nacional de Consumo de Sustancias Psicoactivas en Colombia. 2013.
16. Pagé, M.G., et al. Risk of Opioid Abuse and Biopsychosocial Characteristics Associated With This Risk Among Chronic Pain Patients Attending a Multidisciplinary Pain Treatment Facility. Clin J Pain. 2016 Oct;32(10):859-69.
17. Amsterdam J.V, Van den Brink W. The Misuse of Prescription Opioids: A Threat for Europe?. Current Drug Abuse Reviews 2015; 8: 3-14.
18. Ballantyne, JC. Opioids for the Treatment of Chronic Pain: Mistakes Made, Lessons Learned, and Future Directions. Anesth Analg 2017;125:1769–78.
19. Pergolizzi Jr, J. V., Gharibo, C., Passik, S., Labhsetwar, S., Taylor Jr, R., Pergolizzi, J. S., & Müller-Schwefe, G. Dynamic risk factors in the misuse of opioid analgesics. Journal of psychosomatic research 2012; 72(6): 443-451.
20. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM-5®). American Psychiatric Pub, 2013.
21. American College of Preventive Medicine. Use, Abuse, Misuse, and disposal of prescription pain medication time tool: A Resource from the American College of Preventive Medicine. 2011. Tomado de: http://www.acpm.org/?UseAbuseRxClinRef
22. Ballantyne, J.C, LaForge, K,S. Opioid dependence and addiction during opioid treatment of chronic pain. Pain 2007; 129: 235–255.
23. Johnson S, North R. Opioids excite dopamine neurons by hyperpolarization of local interneurons. J Neurosci. 1992; 12: 483–8.
24. Bonci A, Williams J. Increased probability of GABA release during withdrawal from morphine. J Neurosci. 1997; 17: 796–803.
25. Cami, J., Farre, M. Drug addiction. N Engl J Med 2003; 349: 975–86.
26. Hyman S, Malenka R. Addiction and the brain: the neurobiology of compulsion and its persistence. Nat Rev Neurosci. 2001; 2: 695–703.
27. Robinson T, Berridge K. Addiction. Annu Rev Psychol 2003; 54: 25–53.
28. Chou R, Turner JA, Devine EB, Hansen RN, Sullivan SD, Blazina I, Dana T, Bougatsos C, Deyo RA. The effectiveness and risks of long-term opioid therapy for chronic pain: a systematic review for a National Institutes of Health pathways to prevention workshop. Ann Intern Med. 2015;162:276–86.
29. Vowles K.E, McEntee M.L, Julnes P.S, et al. Rates of opioid misuse, abuse, and addiction in chronic pain: a systematic review and data synthesis. Pain 2015;156:569-76.
30. Webster, L. R. Risk factors for opioid-use disorder and overdose. Anesthesia & Analgesia 2017; 125(5): 1741-1748.
31. McCabe SE, West BT, Boyd CJ. Motives for medical misuse of prescription opioids among adolescents. The Journal of Pain 2013:14: 1208-1216
32. Kirson, N. Y., Scarpati, L. M., Enloe, C. J., Dincer, A. P., Birnbaum, H. G., & Mayne, T. J. The economic burden of opioid abuse: updated findings. Journal of managed care & specialty pharmacy 2017; 23(4): 427-445.
33. Zedler BK, Saunders WB, Joyce AR, Vick CC, Murrelle EL. Validation of a screening risk index for serious prescription opioid-induced respiratory depression or overdose in a US Commercial Health Plan Claims Database. Pain Med. 2017 Mar 6 [Epub ahead of print].
34. Klimas J, et al. Strategies to Identify Patient Risks of Prescription Opioid Addiction When Initiating Opioids for Pain. JAMA Network Open 2019; 2(5): e193365.
35. Grau, LE. Chronic pain, Addiction severity, and misuse of opioids in Cumberland County. Addict Behav. 2012 Mar;37(3):346-9.
36. Pletcher M.J, Kertesz S.G, Kohn M.A, Gonzales R. Trends in opioid prescribing by race/ethnicity for patients seeking care in US emergency departments. Jama. 2008; 299: 70-78.
37. Lanier W.A., Johnson E.M., Rolfs R.T., Friedrichs M.D., Grey T.C. Risk Factors for Prescription Opioid-Related Death, Utah, 2008–2009. Pain Medicine 2012;13: 1580-1589.
38. Akbik H, et al. Validation and clinical application of the Screener and Opioid Assessment for Patients with Pain (SOAPP). J Pain Symptom Manage. 2006; 32(3):287-293.
39. Organización Mundial de la Salud . La prueba de detección de consumo de alcohol, tabaco y sustancias (ASSIST)-Manual para uso en la atención primaria, 2011.
40. Kanouse, A. B., & Compton, P. The epidemic of prescription opioid abuse, the subsequent rising prevalence of heroin use, and the federal response. Journal of pain & palliative care pharmacotherapy 2015; 29(2): 102-114.
41. Lee, Y. H., Brown, D. L., & Chen, H. Y. Current Impact and Application of Abuse-Deterrent Opioid Formulations in Clinical Practice 2017; 20(7):E1003-E1023.
Repositorio EdocUR-U. Rosario
Universidad del Rosario
instacron:Universidad del Rosario